A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

The purpose of this study is to find out how many people with B-cell lymphoma who are at high risk for central nervous system/CNS relapse test positive for cerebral spinal fluid/CSF ctDNA but test negative for CNS involvement using standard tests. The study will also look at how often CNS relapse happens in people with and without detected CSF ctDNA.

Trial Details

NCT ID
NCT06736613
Phase
PHASE2
Sponsor
Memorial Sloan Kettering Cancer Center
Status
RECRUITING
Cancer Type
Brain Cancer
Locations (sample)
  • Basking Ridge, New Jersey, United States
  • Middletown, New Jersey, United States
  • Montvale, New Jersey, United States
  • Commack, New York, United States
  • Harrison, New York, United States

Key Eligibility Criteria

  • Signed Informed Consent.
  • Ability and willingness to comply with the requirements of the study protocol.
  • Age ≥ 18 years old.
  • Diagnosis of the following histologies according to the 2016 WHO Classification for Mature Lymphoid Neoplasms81 along with a specific high-risk cri…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Brain Cancer Trials on Trialify →